🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study was to evaluate the efficacy, safety and tolerability...
Status
Not Yet Recruiting
Location
Breast Cancer Center Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences
Start Date
2025-08-01
Trial ID
NCT07093931
Treatments Being Tested
This is a multicenter, two-arm, exploratory clinical study designed to eval...
Status
Not Yet Recruiting
Location
The Fourth Hospital of Hebei Medical University
Start Date
2026-05
Trial ID
NCT07528898
Treatments Being Tested
This is a prospective, randomized study to compare the efficacy of TP (Taxa...
Status
Completed
Location
Xijing Hospital
Start Date
2021-01-01
Trial ID
NCT07115095
Treatments Being Tested
This is a randomized, double-blind, multicenter trial，parallel control desi...
Status
Completed
Location
Fudan University Cancer Hospital
Start Date
2020-11-23
Trial ID
NCT04629846
Treatments Being Tested
This is a Phase IIIb, multinational, multicenter, randomized, open-label st...
Status
Completed
Location
Centro de Investigaciones Médicas y Desarrollo LC S.R.L
Start Date
2022-07-05
Trial ID
NCT05415215
Breast cancer is the second most common invasive malignancy and the leading...
Status
Terminated
Location
Hospital del Mar
Start Date
2022-05-11
Trial ID
NCT05385705
Treatments Being Tested
This phase I trial studies the side effects and best dose of vaccine therap...
Status
Completed
Location
Ohio State University Medical Center
Start Date
2011-06-21
Trial ID
NCT01376505
Treatments Being Tested
This is an open-label, multi-center, non-randomized study of the safety and...
Status
Completed
Location
Multiple Locations
Start Date
2009-07
Trial ID
NCT00934856
Treatments Being Tested
Currently there are five trastuzumab biosimilars approved by EMA (Ogivri® M...
Status
Unknown
Location
Centre de lutte contre le Cancer JEAN PERRIN, CLERMONT-FERRAND
Start Date
2020-12
Trial ID
NCT04644406
Treatments Being Tested
In HER2-positive metastatic breast cancer, trastuzumab based treatment is t...
Status
Completed
Location
Hopital Sud - Amiens
Start Date
2013-03-03
Trial ID
NCT01835236
Treatments Being Tested